Halma plc (HALMY) Stock
Halma plc, a UK-based company founded in 1894 and headquartered in Amersham, delivers innovative technological solutions across vital safety, health, and environmental markets. Its operations are structured into three distinct segments: Safety, Environmental & Analysis, and Medical.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Halma plc
Halma plc, a UK-based company founded in 1894 and headquartered in Amersham, delivers innovative technological solutions across vital safety, health, and environmental markets. Its operations are structured into three distinct segments: Safety, Environmental & Analysis, and Medical. The Safety division provides a comprehensive suite of products and systems aimed at safeguarding individuals and infrastructure. Offerings include fire detection and specialized suppression technologies, elevator safety mechanisms, security sensors, solutions for managing people and vehicle flow, bespoke interlocks for controlling critical industrial processes, and systems for explosion protection and corrosion monitoring. This segment caters to diverse sectors such as fire protection, industrial access control, and transport safety. The Environmental & Analysis segment focuses on instruments and technologies for monitoring and enhancing environmental quality. Its portfolio features optical, optoelectronic, and spectral imaging systems, along with advanced monitoring solutions for water, air, and gases. It also supplies instruments for detecting hazardous gases, analyzing air quality, and systems for water treatment and analysis. Primary markets for this segment include environmental observation, water management, and gas sensing. Finally, the Medical division supplies crucial components and sophisticated systems to the healthcare industry. This encompasses essential fluidic components utilized by medical diagnostics and original equipment manufacturers, laboratory devices that furnish critical information for patient health assessment and decision-making, and technologies that facilitate life-science discovery, development, and in-vitro diagnostic applications. This division primarily serves the life sciences, health assessment, and therapeutic solutions sectors.
Halma plc is headquartered in GB.
Halma plc (HALMY) stock trades at $98.60 with a market capitalization of $18.62B. The stock is valued at a price-to-earnings (P/E) ratio of 37.37, price-to-book of 6.41, price-to-sales of 5.36. Over the past 52 weeks the stock has ranged between $85.72 and $134.00, and currently trades 26.4% below its 52-week high. It pays a dividend yielding 0.82%.
On profitability, Halma plc generates a return on equity (ROE) of 17.92%, above the typical market average, return on capital employed of 16.48%, an operating margin of 20.36%, a net profit margin of 14.42%.
In its most recent fiscal year, Halma plc reported annual revenue of $2.6B, net profit of $372.0M, revenue has compounded at 14.4% a year over the last five years, profit at 12.9% a year.
The balance sheet shows a debt-to-equity ratio of 0.42 — a conservative balance sheet with little leverage risk, a current ratio of 2.14, total assets of $3.7B, $143.0M in cash and equivalents.
HALMY has an average daily trading volume of 49,922 shares, a beta of 0.98.
Official website: www.halma.com